11
Researchers in Sweden have developed an advanced technique to produce insulin-producing cells from human stem cells, offering promising progress toward a more effective treatment for type 1 diabetes.
The study, conducted by scientists from the Karolinska Institute and the Royal Institute of Technology (KTH), showed that the newly generated cells demonstrated high efficiency in laboratory tests and successfully reversed diabetes symptoms in mice by restoring their ability to regulate blood sugar levels.
According to the findings published on April 18, 2026, this scientific achievement could pave the way for future therapies that reduce or eliminate the need for daily insulin injections in people living with type 1 diabetes.
